STOCK TITAN

Bayview Legacy LLC cuts Arteris (AIP) stake in 192,686-share 10b5-1 sale

Filing Impact
(Very High)
Filing Sentiment
(Very Negative)
Form Type
4

Rhea-AI Filing Summary

Bayview Legacy, LLC, a 10% owner of Arteris, Inc., reported open-market sales of 192,686 shares of Arteris common stock. The trades occurred on July 2, 2026 across eight transactions at weighted average prices between $34.77 and $43.24 per share. The filing notes that these sales were made pursuant to a Rule 10b5-1 trading plan adopted by Bayview’s manager, K. Charles Janac, on December 12, 2025, indicating the transactions were pre-scheduled rather than opportunistic.

Positive

  • None.

Negative

  • None.
Insider Bayview Legacy, LLC
Role null
Sold 192,686 shs ($7.00M)
Type Security Shares Price Value
Sale Common Stock 11,000 $37.6074 $414K
Sale Common Stock 39,880 $36.6961 $1.46M
Sale Common Stock 26,348 $35.6723 $940K
Sale Common Stock 80,042 $34.7706 $2.78M
Sale Common Stock 24,691 $38.8891 $960K
Sale Common Stock 5,482 $39.7237 $218K
Sale Common Stock 2,500 $40.7832 $102K
Sale Common Stock 2,743 $43.2358 $119K
Holdings After Transaction: Common Stock — 8,736,733 shares (Indirect, See Footnote)
Footnotes (1)
  1. Transaction made pursuant to a 10b5-1 trading plan that was adopted by K. Charles Janac, as the manager of Bayview Legacy, LLC, on December 12, 2025. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $40.44 to $40.90 inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $42.57 to $43.51 inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. K. Charles Janac, in his individual capacity, has separately filed a Form 4 on the date hereof reporting the same transaction given his beneficial ownership of the reported security through Bayview Legacy, LLC, which he controls as its manager. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $37.20 to $38.17 inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. K. Charles Janac is the manager of Bayview Legacy, LLC and as such is deemed to have voting and dispositive power over the shares beneficially owned by Bayview Legacy, LLC. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $36.20 to $37.19 inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $35.20 to $36.19 inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $34.20 to $35.19 inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $38.27 to $39.25 inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $39.30 to $40.29 inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Shares sold 192,686 shares Total common shares sold on July 2, 2026
Number of transactions 8 sales Open-market common stock sales on July 2, 2026
Highest reported weighted average price $43.2358/share One of the July 2, 2026 sale prices
Lowest reported weighted average price $34.7706/share One of the July 2, 2026 sale prices
Net share direction -192,686 shares Net-sell activity per transaction summary
10b5-1 plan adoption date December 12, 2025 Adoption date of trading plan governing these sales
Insider status 10% owner Bayview Legacy, LLC ownership classification
Rule 10b5-1 trading plan regulatory
"Transaction made pursuant to a 10b5-1 trading plan that was adopted..."
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
weighted average sale price financial
"The price reported in Column 4 is a weighted average sale price."
beneficial ownership financial
"given his beneficial ownership of the reported security through Bayview Legacy, LLC..."
Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.
voting and dispositive power regulatory
"is deemed to have voting and dispositive power over the shares..."
open market or private transaction financial
"Sale in open market or private transaction"
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What did Bayview Legacy, LLC report in its latest Form 4 for Arteris (AIP)?

Bayview Legacy, LLC reported selling 192,686 shares of Arteris common stock in eight open-market transactions on July 2, 2026. These indirect sales reflect activity by a 10% owner and were executed under a pre-established Rule 10b5-1 trading plan.

How many Arteris (AIP) shares did Bayview Legacy, LLC sell and at what prices?

Bayview Legacy, LLC sold 192,686 Arteris shares in total. The eight reported open-market transactions used weighted average sale prices ranging from about $34.77 to $43.24 per share, with detailed price ranges available in the filing’s weighted-average footnotes.

Were Bayview Legacy, LLC’s Arteris (AIP) share sales made under a Rule 10b5-1 plan?

Yes. The Form 4 states the transactions were made under a Rule 10b5-1 trading plan adopted on December 12, 2025. Such plans pre-schedule trades, meaning the timing of these July 2, 2026 sales was set in advance rather than decided spontaneously.

Is Bayview Legacy, LLC a significant shareholder of Arteris (AIP)?

Bayview Legacy, LLC is identified in the filing as a 10% owner of Arteris. The reported transactions involve indirect holdings, with K. Charles Janac controlling Bayview as its manager and deemed to have voting and dispositive power over its beneficially owned shares.

What role does K. Charles Janac play in Bayview Legacy, LLC’s Arteris (AIP) holdings?

The footnotes explain that K. Charles Janac is the manager of Bayview Legacy, LLC and is deemed to have voting and dispositive power over its Arteris shares. He also filed a separate Form 4 reporting the same transactions due to his beneficial ownership through Bayview.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Bayview Legacy, LLC

(Last)(First)(Middle)
C/O ARTERIS, INC.
900 E. HAMILTON AVE., SUITE 300

(Street)
CAMPBELL CALIFORNIA 95008

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Arteris, Inc. [ AIP ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
DirectorX10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
07/02/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock07/02/2026S(1)(2)11,000D$37.6074(3)8,736,733ISee Footnote(4)
Common Stock07/02/2026S(1)(2)39,880D$36.6961(5)8,696,853ISee Footnote
Common Stock07/02/2026S(1)(2)26,348D$35.6723(6)8,670,505ISee Footnote
Common Stock07/02/2026S(1)(2)80,042D$34.7706(7)8,590,463ISee Footnote
Common Stock07/02/2026S(1)(2)24,691D$38.8891(8)8,565,772ISee Footnote
Common Stock07/02/2026S(1)(2)5,482D$39.7237(9)8,560,290ISee Footnote
Common Stock07/02/2026S(1)(2)2,500D$40.7832(10)8,557,790ISee Footnote
Common Stock07/02/2026S(1)(2)2,743D$43.2358(11)8,555,047ISee Footnote
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. Transaction made pursuant to a 10b5-1 trading plan that was adopted by K. Charles Janac, as the manager of Bayview Legacy, LLC, on December 12, 2025.
2. K. Charles Janac, in his individual capacity, has separately filed a Form 4 on the date hereof reporting the same transaction given his beneficial ownership of the reported security through Bayview Legacy, LLC, which he controls as its manager.
3. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $37.20 to $38.17 inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
4. K. Charles Janac is the manager of Bayview Legacy, LLC and as such is deemed to have voting and dispositive power over the shares beneficially owned by Bayview Legacy, LLC.
5. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $36.20 to $37.19 inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
6. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $35.20 to $36.19 inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
7. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $34.20 to $35.19 inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
8. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $38.27 to $39.25 inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
9. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $39.30 to $40.29 inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
10. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $40.44 to $40.90 inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
11. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $42.57 to $43.51 inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Remarks:
/s/ K. Charles Janac07/06/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)